Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 1 355 JPY -0.15%
Market Cap: 40.8B JPY

Daito Pharmaceutical Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Daito Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
EPS (Diluted)
ÂĄ66
CAGR 3-Years
-18%
CAGR 5-Years
-15%
CAGR 10-Years
-3%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
ÂĄ20
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
ÂĄ151
CAGR 3-Years
67%
CAGR 5-Years
20%
CAGR 10-Years
-11%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
ÂĄ850
CAGR 3-Years
61%
CAGR 5-Years
26%
CAGR 10-Years
12%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
ÂĄ241
CAGR 3-Years
-12%
CAGR 5-Years
14%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
ÂĄ69
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
40.6B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
1 660.08 JPY
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
66.2 JPY

Based on the financial report for Aug 31, 2025, Daito Pharmaceutical Co Ltd's EPS (Diluted) amounts to 66.2 JPY.

What is Daito Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-3%

Over the last year, the EPS (Diluted) growth was -37%. The average annual EPS (Diluted) growth rates for Daito Pharmaceutical Co Ltd have been -18% over the past three years , -15% over the past five years , and -3% over the past ten years .

Back to Top